📣 VC round data is live. Check it out!

MEDCAMP Valuation Multiples

Discover revenue and EBITDA valuation multiples for MEDCAMP and similar public comparables like ENA, Korporacja Gospodarcza Efekt, Bolkan Property, Euromayor SA de Inversiones and more.

MEDCAMP Overview

About MEDCAMP

MEDCAMP SA is engaged in redevelopment investments. The company provides clients with the quality of development projects prepared for implementation based on revitalized real estates. It also engaged in the acquisition, management, redevelopment and upgrade, as well as rental of commercial properties, including office areas and warehouses.


Founded

1998

HQ

Poland

Employees

N/A

Financials (FY)

Revenue: -
EBITDA: $315K

EV

$8M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MEDCAMP Financials

MEDCAMP reported last fiscal year revenue of - and EBITDA of $315K.

In the same fiscal year, MEDCAMP generated $315K in EBITDA and had net loss of ($54K).


MEDCAMP P&L

In the most recent fiscal year, MEDCAMP reported revenue of - and EBITDA of $315K.

MEDCAMP is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.

See analyst estimates for MEDCAMP
Last FY202320242025202620272028
Gross Profit-($2K)($0K)-
EBITDA$315K($2M)($502K)$315K
Net Profit($54K)($2M)($473K)($54K)
Net Debt$19K---

Financial data powered by Morningstar, Inc.

MEDCAMP Stock Performance

MEDCAMP has current market cap of $8M, and enterprise value of $8M.

Market Cap Evolution


MEDCAMP's stock price is $0.22.

MEDCAMP share price decreased by 0.8% in the last 30 days, and increased by 3.6% in the last year.

See more trading valuation data for MEDCAMP
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M$8M-0.8%-0.8%2.6%3.6%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MEDCAMP Valuation Multiples

MEDCAMP trades at 25.1x EV/EBITDA.

See NTM and 2027E valuation multiples for MEDCAMP

MEDCAMP Financial Valuation Multiples

As of June 2, 2026, MEDCAMP has market cap of $8M and EV of $8M.

MEDCAMP has a P/E ratio of (149.6x).

Last FY202320242025202620272028
EV/EBITDA25.1x(3.8x)(15.7x)25.1x
EV/EBIT(143.9x)(90.8x)(121.8x)(143.9x)
EV/Gross Profit-n/mn/m-
P/E(149.6x)(3.4x)(17.1x)(149.6x)
EV/FCF(118.2x)(14.0x)(93.6x)(118.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MEDCAMP Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MEDCAMP Margins & Growth Rates

See estimated margins and future growth rates for MEDCAMP

MEDCAMP Growth Rates

23/2424/2526/2727/2828/29
Gross Profit Growth(77%)-
EBITDA Growth(76%)(163%)
EBIT Growth(25%)(15%)
Net Profit Growth(80%)(89%)
FCF Growth(85%)(21%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

MEDCAMP Competitors

MEDCAMP competitors include ENA, Korporacja Gospodarcza Efekt, Bolkan Property, Euromayor SA de Inversiones, Dragon Capital Group, Octava, Wise Finance, Real Bulland, Cleanbnb and Fastator.

Most MEDCAMP public comparables operate across Real Estate Development.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
ENA0.8x-(4.9x)-
Korporacja Gospodarcza Efekt1.3x-5.1x-
Bolkan Property14.1x-35.9x-
Euromayor SA de Inversiones----
Dragon Capital Group----
Octava28.1x-(2.5x)-
Wise Finance4.5x-(48.5x)-
Real Bulland41.7x-32.0x-

This data is available for Pro users. Sign up to see all MEDCAMP competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MEDCAMP

When was MEDCAMP founded?MEDCAMP was founded in 1998.
Where is MEDCAMP headquartered?MEDCAMP is headquartered in Poland.
Is MEDCAMP publicly listed?Yes, MEDCAMP is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of MEDCAMP?MEDCAMP trades under MDP ticker.
When did MEDCAMP go public?MEDCAMP went public in 2007.
Who are competitors of MEDCAMP?MEDCAMP main competitors include ENA, Korporacja Gospodarcza Efekt, Bolkan Property, Euromayor SA de Inversiones, Dragon Capital Group, Octava, Wise Finance, Real Bulland, Cleanbnb, Fastator.
What is the current market cap of MEDCAMP?MEDCAMP's current market cap is $8M.
Is MEDCAMP profitable?No, MEDCAMP is not profitable.
How many companies MEDCAMP has acquired to date?MEDCAMP hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies MEDCAMP has invested to date?MEDCAMP hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to MEDCAMP

Lists including MEDCAMP

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial